Australia’s COVID-19 Shot Injury Compensation System Criticized for Delays and Alleged Threats
Australia’s COVID-19 shot injury compensation system is under scrutiny, with injured individuals describing a slow, complex, and distressing process that has left many without timely support while their health and financial situations worsen.1 2 The federal government introduced the COVID-19 Vaccine Claims Scheme in 2021 as a “simple and quick” way to compensate people who […]
CDC Considers New Medical Code to Classify Vaccine Injuries
The U.S. Centers for Disease Control and Prevention (CDC) is considering a proposal to formally recognize injuries associated with COVID-19 vaccinations as a diagnosable condition that can be recorded in medical records.1 The International Classification of Diseases (ICD-10), a standardized system used to classify diagnoses, symptoms, and procedures, could be updated under the proposal. Introduced […]
Study Finds All Major Pharmaceutical Companies Implicated in Bribery Schemes
A study published in February 2026 in the Journal of Law, Medicine & Ethics is the first to compile decades of Organization for Economic Cooperation and Development (OECD) enforcement records into a single analysis. Researchers Kohler, Khan, and Bowra reviewed OECD Working Group on Bribery reports from 1999 through early 2025 and found that virtually […]
U.S. Fertility Rates Near Historic Lows
Fertility rates in the United States are now among the lowest levels ever recorded, based on provisional data released by the U.S. Centers for Disease Control and Prevention (CDC) earlier this month. According to the CDC report, the general fertility rate declined to 53.1 births per 1,000 women ages 15-44, down 23 percent since 2007, […]
Patients Request Blood from Donors Who Have Not Received mRNA COVID-19 Shots
A growing number of patients are requesting blood transfusions from donors who have not gotten the COVID19 shot, according to a Mar. 28, 2026 report published in the journal Transfusion. In the report, researchers at Vanderbilt Medical Center Medical Center evaluated 15 cases over a period of two years between 2024 and 2025 in which […]
Pfizer/Valneva Aim for FDA Approval of mRNA Shot for Lyme Disease
On Mar. 23, 2026, Pfizer, Inc. of New York City, NY and Valneva SE of Saint-Herblain, France announced that they would seek regulatory approval from the U.S. Food and Drug Administration (FDA) for an experimental mRNA (messenger ribonucleic acid) biologic shot against Lyme disease that they have jointly been developing since 2020. The shot, designated […]